IJE Software logoIJEsoft
ServicesPortfolioAboutStackNewsBlogPartnerPH NewsMarketsContactGet in touch
← Back to Philippines Business News
Manila Times Business

sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety

This world's first clinical study on sweet proteins, reflects the clinical relevance of Amai Protein's sweelin®. The double-blind, randomized, crossover clinical study confirmed that sweelin® does not affect blood glucose, insulin and GLP-1 levels compared to stevia and dextrose in healthy adults. sweelin® is a next-generation sweet protein that enables significant sugar reduction and replaces conventional sweeteners with a protein-based alternative, designed to deliver superior clean taste, com

This is an excerpt. Read the full article at the original source:

Source: manilatimes.net

More from Manila Times Business

DEMIRE: Major shareholders launch structured sale process

Just now

AMAYA BIG SKY CAPITAL ANNOUNCES RESIGNATION OF DIRECTOR

Just now

Fairfax Announces Acquisition of Additional Orla Mining Ltd. Common Shares

Just now

Nocera Inc. (Nasdaq:NCRA) Advances AI and Acquisition Strategy Through Binding Venture Platform Agreement with U.S.-Based Digital Innovations Group

Just now

Your Daily Briefing

AI business companion — delivered every morning

Markets, PH news, financial insights, and devotionals — curated by AI and sent at 7 AM PHT. Pick your topics below.

Devotionals
Blog Topics
HR & Workforce
Real Estate & Property
News & Markets

1 topic selected